IPG Investment Advisors LLC Has $11.13 Million Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

IPG Investment Advisors LLC decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 26.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,192,589 shares of the pharmacy operator’s stock after selling 436,146 shares during the quarter. Walgreens Boots Alliance accounts for about 2.5% of IPG Investment Advisors LLC’s holdings, making the stock its 10th biggest position. IPG Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $11,127,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. State Street Corp raised its stake in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after acquiring an additional 6,569,223 shares during the period. Norges Bank bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $58,241,000. Two Sigma Advisers LP acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $24,226,000. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock valued at $805,506,000 after buying an additional 2,279,495 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after acquiring an additional 2,185,950 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently weighed in on WBA. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price target for the company from $11.00 to $9.00 in a research note on Friday, February 28th. StockNews.com initiated coverage on Walgreens Boots Alliance in a report on Wednesday. They issued a “hold” rating for the company. Finally, Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Trading Up 0.3 %

NASDAQ WBA opened at $11.19 on Friday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $21.74. The business’s fifty day moving average is $10.83 and its 200 day moving average is $9.91. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a market cap of $9.67 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.66 earnings per share. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.